Kiora Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Kiora Pharmaceuticals

12/07/2022 14:40

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 27 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 23 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Kiora Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 27 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Kiora Pharmaceuticals Inc shares had fallen by 5.2% this
quarter and lost 70.5% so far this year.
    * The company reported a quarterly loss of $3.57 million.
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated July 12 at 01:40 p.m.  ​All
figures in US dollars unless otherwise stated